BRAF and melanoma: Although cell culture models for induced melanoma cell drug resistance have not been tested here, there may be a legitimate hope that different kinds of drug resistance in melanoma cells may also be overcome by these combination treatments, as the targets of BH3 mimetics are clearly distinct from those of BRAF inhibitors and immunotherapy.